Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Lerkevang Grove

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Ugeskrift for Laeger|June 3, 2022
Erik Lerkevang Grove
Current Pharmaceutical Design|June 26, 2012
Editorial: Paving the way for improved antiplatelet therapyErik Lerkevang Grove
BMJ Case Reports|August 24, 2017
Large atrial mass in a patient with Crohn's disease: organised thrombus mimicking a myxomaErik Lerkevang Grove
Danish Medical Journal|September 7, 2012
Antiplatelet effect of aspirin in patients with coronary artery diseaseErik Lerkevang Grove
Ugeskrift for Laeger|June 11, 2015
[Skin necrosis and consequences of accidental subcutaneous administration of amiodarone]Erik Lerkevang Grove
BMJ Case Reports|September 10, 2014
Left atrial papillary fibroelastoma as an unusual cause of myocardial infarctionFarhad Waziri, Erik Lerkevang Grove
Expert Opinion on Drug Metabolism & Toxicology|July 28, 2012
Combining aspirin and proton pump inhibitors: for whom the warning bell tolls?Morten Würtz, Erik Lerkevang Grove
Ugeskrift for Laeger|September 10, 2013
[Oral antiplatelet agents can still be used along with proton pump inhibitors in spite of drug interactions]Morten Würtz, Erik Lerkevang Grove
The American Journal of Case Reports|October 1, 2015
Life-Threatening Contraceptive-Related Pulmonary Embolism in a 14-Year-Old Girl with Hereditary ThrombophiliaMaja Hellfritzsch, Erik Lerkevang Grove
Current Pharmaceutical Design|June 26, 2012
Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importanceMorten Würtz, Erik Lerkevang Grove
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Ugeskrift for Laeger|June 3, 2022
Erik Lerkevang Grove
Current Pharmaceutical Design|June 26, 2012
Editorial: Paving the way for improved antiplatelet therapyErik Lerkevang Grove
BMJ Case Reports|August 24, 2017
Large atrial mass in a patient with Crohn's disease: organised thrombus mimicking a myxomaErik Lerkevang Grove
Danish Medical Journal|September 7, 2012
Antiplatelet effect of aspirin in patients with coronary artery diseaseErik Lerkevang Grove
Ugeskrift for Laeger|June 11, 2015
[Skin necrosis and consequences of accidental subcutaneous administration of amiodarone]Erik Lerkevang Grove
BMJ Case Reports|September 10, 2014
Left atrial papillary fibroelastoma as an unusual cause of myocardial infarctionFarhad Waziri, Erik Lerkevang Grove
Expert Opinion on Drug Metabolism & Toxicology|July 28, 2012
Combining aspirin and proton pump inhibitors: for whom the warning bell tolls?Morten Würtz, Erik Lerkevang Grove
Ugeskrift for Laeger|September 10, 2013
[Oral antiplatelet agents can still be used along with proton pump inhibitors in spite of drug interactions]Morten Würtz, Erik Lerkevang Grove
The American Journal of Case Reports|October 1, 2015
Life-Threatening Contraceptive-Related Pulmonary Embolism in a 14-Year-Old Girl with Hereditary ThrombophiliaMaja Hellfritzsch, Erik Lerkevang Grove
Current Pharmaceutical Design|June 26, 2012
Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importanceMorten Würtz, Erik Lerkevang Grove
Pageof 20